Successful Mirtazapine Treatment of an 81-Year-old Patient With Syndrome of Inappropriate Antidiuretic Hormone Secretion

Abstract

Elderly patients are at a higher risk for inappropriate antidiuretic hormone secretion when treated with antidepressants. In response to severe depressive symptoms, we initiated treatment with citalopram of an 81-year-old female patient with slightly reduced sodium and chloride levels. The sodium and chloride levels decreased continuously during treatment with citalopram; six days after the citalopram was discontinued, sodium and chloride levels returned to normal. We then switched treatment to mirtazapine. Close monitoring revealed that the patient's sodium and chloride levels never decreased and the patient did not relapse for more than two months. This case study indicates that treatment with citalopram may worsen preexisting hyponatremia. Mirtazapine appears to be safe for use in high-risk, elderly patients.

References

• 1 Azaz-Livshits T, Hershko A, Ben Chetrit E. Paroxetine associated hepatotoxicity: a report of 3 cases and a review of the literature.  Pharmacopsychiatry. 2002;  35 112-115
• 2 Barclay TS, Lee AJ. Citalopram-associated SIADH.  Ann Pharmacother. 2002;  36 1558-1563
• 3 Blass DM, Pearson VE. SIADH with multiple antidepressants in a geriatric patient.  J Clin Psychiatry. 2000;  61 448-449
• 4 Degner D, Grohmann R, Kropp S, Ruther E, Bender S, Engel RR, Schmidt LG. Severe adverse drug reactions of antidepressants: Results of the German multicenter drug surveillance program AMSP.  Pharmacopsychiatry. 2004;  37 (Suppl 1) 39-45
• 5 Flores G, Perez-Patrigeon S, Cobos-Ayala C, Vergara J. Severe symptomatic hyponatremia during citalopram therapy: a case report.  BMC Nephrol. 2004;  5 2
• 6 Kirby D, Harrigan S, Ames D. Hyponatraemia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit.  Int J Geriatr Psychiatry. 2002;  17 231-237
• 7 Leung VP, Chiu HF, Lam LC. Hyponatremia associated with paroxetine.  Pharmacopsychiatry. 1998;  31 32-34
• 8 Liu BA, Mittmann N, Knowles SR, Shear NH. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports.  CMAJ. 1996;  155 519-527
• 9 Miehle K, Paschke R, Koch CA. Citalopram therapy as a risk factor for symptomatic hyponatremia caused by the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): a case report.  Pharmacopsychiatry. 2005;  38 181-182
• 10 Odeh M, Beny A, Oliven A. Severe symptomatic hyponatremia during citalopram therapy.  Am J Med Sci. 2001;  321 159-160
• 11 Pollock BG. Adverse reactions of antidepressants in elderly patients.  J Clin Psychiatry. 1999;  60 (Suppl 20) 4-8
• 12 Rai A, Whaley-Connell A, McFarlane S, Sowers JR. Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonism.  Am J Nephrol. 2006;  26 579-589
• 13 Roxanas MG. Mirtazapine-induced hyponatraemia.  Med J Aust. 2003;  179 453-454
• 14 Settle Jr EC. Antidepressant drugs: disturbing and potentially dangerous adverse effects.  J Clin Psychiatry. 1998;  59 (Suppl 16) 25-30
• 15 Sharma H, Pompei P. Antidepressant-induced hyponatraemia in the aged. Avoidance and management strategies.  Drugs Aging. 1996;  8 430-435
• 16 Spigset O, Hedenmalm K. Hyponatremia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs.  Drug Safety. 1995;  12 209-225

Correspondence